Alvaro Davila, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Davila’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence G75546 · Current
Licensed to practise in California · since 1992 · expires 2028-10-31 · University of Pennsylvania School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$28,326
Medicare paid this office $28,326 for 131 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,572 | $114 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 19 | $4,187 | $209 |
| Return visit (30+ min) | 23 | $1,857 | $77 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,672 | $98 |
| Biopsy of large bowel using a flexible endoscope | 20 | $1,597 | $80 |
See all 9 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,572 | $114 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 19 | $4,187 | $209 |
| Return visit (30+ min) | 23 | $1,857 | $77 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,672 | $98 |
| Biopsy of large bowel using a flexible endoscope | 20 | $1,597 | $80 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,392 | $107 |
| Short return visit (20+ min) | 14 | $835 | $56 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 20 | $482 | $21 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 43 | $207 | $5 |
Procedures Medicare counted
| Colonoscopy | 61 | More than 68% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 60 | More than 67% of doctors who do this |
Who their Medicare patients are
131 Original Medicare patients in 2024. Average age 72 · Under 65 16% · 85 and older 14% · Women 53% · Also on Medicaid 76% · Health risk score 2.25. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 50% · Chronic kidney disease 36% · Heart failure 28% · Coronary heart disease 27% · Atrial fibrillation 25% · Depression 24% · Dementia 18% · Cancer 16% · COPD 14% · Stroke 12%.
The office billed $426,012, Medicare allowed $37,879 and paid $28,326; for 295 services of 32 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 131 | 295 | 72 | 2.25 | $426,012 | $28,326 |
| 2023 | 154 | 365 | 70 | 2.20 | $431,310 | $32,045 |
| 2022 | 123 | 275 | 69 | 2.14 | $276,330 | $22,533 |
| 2021 | 142 | 321 | 69 | 2.35 | $239,419 | $22,379 |
| 2020 | 160 | 363 | 70 | 2.14 | $352,104 | $28,297 |
| 2019 | 199 | 447 | 70 | 2.04 | $440,995 | $39,798 |
| 2018 | 151 | 368 | 69 | 1.69 | $271,871 | $32,041 |
| 2014 | 143 | 258 | 69 | 1.31 | $184,125 | $24,978 |
| 2013 | 170 | 387 | 69 | 1.54 | $290,960 | $40,339 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,487 | $125 |
| Return visit (30+ min) | 43 | $4,289 | $79 |
| Biopsy of large bowel using a flexible endoscope | 23 | $2,803 | $122 |
| Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | 12 | $2,799 | $233 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,614 | $101 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,341 | $195 |
| Short return visit (20+ min) | 23 | $1,379 | $49 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,132 | $94 |
| Review by radiologist of image from tube placement into bile duct using an endoscope | 17 | $388 | $22 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 73 | $360 | $5 |
2022: 9 services
| Return visit (30+ min) | 30 | $3,305 | $94 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $3,108 | $222 |
| Biopsy of large bowel using a flexible endoscope | 24 | $2,635 | $110 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,203 | $130 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,724 | $101 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,640 | $91 |
| Short return visit (20+ min) | 15 | $1,081 | $60 |
| Telephone medical discussion with physician, 5-10 minutes | 20 | $432 | $21 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 61 | $307 | $5 |
2021: 6 services
| Telephone medical discussion with physician, 5-10 minutes | 72 | $3,453 | $33 |
| Return visit (30+ min) | 27 | $2,673 | $95 |
| Biopsy of large bowel using a flexible endoscope | 19 | $2,540 | $134 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,536 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,434 | $84 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 46 | $229 | $5 |
2020: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 14 | $2,776 | $198 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $2,460 | $72 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,434 | $122 |
| Telephone medical discussion with physician, 11-20 minutes | 39 | $2,350 | $45 |
| Biopsy of large bowel using a flexible endoscope | 26 | $2,034 | $78 |
| Return visit (30+ min) | 25 | $1,674 | $49 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,521 | $89 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,202 | $80 |
| Telephone medical discussion with physician, 5-10 minutes | 26 | $576 | $22 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 53 | $266 | $5 |
2019: 9 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $5,797 | $193 |
| Return visit (30+ min) | 62 | $5,244 | $66 |
| Biopsy of large bowel using a flexible endoscope | 49 | $4,398 | $90 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 40 | $3,840 | $96 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,767 | $111 |
| New patient visit (45+ min) | 18 | $1,659 | $92 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,212 | $93 |
| Short return visit (20+ min) | 23 | $979 | $35 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 78 | $401 | $5 |
2018: 10 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 18 | $4,210 | $234 |
| Return visit (30+ min) | 33 | $3,744 | $69 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 33 | $2,918 | $88 |
| Biopsy of large bowel using a flexible endoscope | 28 | $2,759 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $1,830 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,711 | $107 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,627 | $136 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,370 | $105 |
| Short return visit (20+ min) | 24 | $1,290 | $44 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 70 | $341 | $5 |
2014: 6 services
| Return visit (30+ min) | 69 | $5,069 | $52 |
| Biopsy of large bowel using a flexible endoscope | 16 | $3,184 | $199 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $3,166 | $264 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,678 | $122 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,926 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,153 | $64 |
2013: 6 services
| Return visit (30+ min) | 92 | $9,958 | $59 |
| Biopsy of large bowel using a flexible endoscope | 25 | $4,624 | $185 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 31 | $3,867 | $121 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,420 | $118 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 11 | $3,235 | $270 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,745 | $116 |
Medicaid work
$12,840 in 2024
Medicaid paid $12,840 for 1,700 billed services this clinician did in 2024, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Service | 244 | $4,547 |
| Return visit (30+ min) | 183 | $2,182 |
| COLONOSCOPY AND BIOPSY | 61 | $1,228 |
| Diagnostic upper gastrointestinal endoscopy | 25 | $1,040 |
| COLONOSCOPY W/LESION REMOVAL | 52 | $1,003 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 43 | $958 |
| TISSUE EXAM BY PATHOLOGIST | 263 | $879 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 214 | $315 |
| Upper gastrointestinal endoscopy with biopsy | 40 | $281 |
| Short return visit (20+ min) | 22 | $251 |
| Special stain including interpretation and report; Group I for microorganisms (eg, acid fast, methenamine silver) | 50 | $92 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 128 | $64 |
| 2024 | 1,700 | 18 | 44 | $12,840 |
| 2023 | 1,348 | 11 | 33 | $7,103 |
| 2022 | 460 | 8 | 41 | $4,998 |
| 2021 | 354 | 7 | 26 | $5,798 |
| 2020 | 217 | 5 | 28 | $2,460 |
| 2019 | 437 | 11 | 32 | $7,440 |
| 2018 | 1,028 | 12 | 37 | $11,215 |
See the largest Medicaid services in earlier years
2023
| Upper gastrointestinal endoscopy with biopsy | 91 | $2,621 |
| TISSUE EXAM BY PATHOLOGIST | 315 | $1,651 |
| Return visit (30+ min) | 193 | $972 |
| COLONOSCOPY AND BIOPSY | 27 | $469 |
| Service | 173 | $433 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 289 | $349 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 19 | $257 |
| Special stain including interpretation and report; Group I for microorganisms (eg, acid fast, methenamine silver) | 74 | $173 |
| Short return visit (20+ min) | 31 | $99 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 120 | $79 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 16 | $0 |
2022
| COLONOSCOPY AND BIOPSY | 40 | $1,647 |
| TISSUE EXAM BY PATHOLOGIST | 39 | $849 |
| Return visit (30+ min) | 61 | $690 |
| Upper gastrointestinal endoscopy with biopsy | 18 | $545 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 14 | $498 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 254 | $497 |
| Short return visit (20+ min) | 20 | $260 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 14 | $12 |
2021
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 27 | $1,385 |
| Return visit (30+ min) | 109 | $1,193 |
| COLONOSCOPY AND BIOPSY | 25 | $954 |
| TISSUE EXAM BY PATHOLOGIST | 35 | $952 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 18 | $764 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 107 | $435 |
| Short return visit (20+ min) | 33 | $114 |
2020
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 110 | $1,149 |
| TISSUE EXAM BY PATHOLOGIST | 28 | $831 |
| Return visit (30+ min) | 52 | $302 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 12 | $120 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 15 | $58 |
2019
| COLONOSCOPY AND BIOPSY | 34 | $2,216 |
| Diagnostic upper gastrointestinal endoscopy | 14 | $1,441 |
| Upper gastrointestinal endoscopy with biopsy | 25 | $1,016 |
| Return visit (30+ min) | 140 | $749 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 111 | $730 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $584 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 33 | $252 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 14 | $225 |
| New patient visit (45+ min) | 16 | $142 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 21 | $50 |
| Short return visit | 16 | $35 |
2018
| TISSUE EXAM BY PATHOLOGIST | 205 | $4,185 |
| Service | 207 | $3,308 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 221 | $1,055 |
| COLONOSCOPY AND BIOPSY | 27 | $849 |
| Upper gastrointestinal endoscopy with biopsy | 28 | $471 |
| Return visit (30+ min) | 142 | $425 |
| IP/OBS CONSLTJ NEW/EST PT MOD MDM 60 MINUTES | 16 | $345 |
| Special stain including interpretation and report; Group I for microorganisms (eg, acid fast, methenamine silver) | 51 | $301 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $141 |
| Short return visit (20+ min) | 15 | $53 |
| 5% dextrose/normal saline (500 ml = 1 unit) | 51 | $49 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 53 | $33 |
Drugs they prescribed that Part D paid
$220,473
Pharmacies billed $220,473 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 466) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
376 generic and fewer than 11 brand-name prescriptions · $220,473 in drug cost · 19 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ocaliva | 12 | $113,612 | $9,468 |
| Xifaxan | 15 | $44,153 | $2,944 |
| Vemlidy | 24 | $33,997 | $1,417 |
| Trulance | 11 | $5,786 | $526 |
| Lamivudine Hbv | 12 | $2,122 | $177 |
See all 16 drugs
| Ocaliva | 12 | $113,612 | $9,468 |
| Xifaxan | 15 | $44,153 | $2,944 |
| Vemlidy | 24 | $33,997 | $1,417 |
| Trulance | 11 | $5,786 | $526 |
| Lamivudine Hbv | 12 | $2,122 | $177 |
| Esomeprazole Magnesium | 25 | $2,055 | $82 |
| Ursodiol | 22 | $1,317 | $60 |
| Entecavir | 19 | $947 | $50 |
| Pantoprazole | 66 | $735 | $11 |
| Lactulose | 15 | $646 | $43 |
| Omeprazole | 52 | $646 | $12 |
| Loperamide | 24 | $484 | $20 |
| Lansoprazole | 24 | $318 | $13 |
| Spironolactone | 22 | $159 | $7 |
| Carvedilol | 16 | $76 | $5 |
| Amitriptyline | 20 | $64 | $3 |
Year by year
| 2024 | 466 | 66 | 0% (0) | None | $220,473 |
| 2023 | 514 | 78 | 0% (0) | 19% | $213,755 |
| 2022 | 479 | 82 | 0% (0) | None | $206,387 |
| 2021 | 633 | 121 | 2% (14) | 25% | $212,171 |
| 2020 | 582 | 112 | None | 28% | $178,722 |
| 2019 | 648 | 119 | 2% (12) | 31% | $183,626 |
| 2018 | 656 | 127 | 2% (13) | 32% | $215,485 |
| 2017 | 596 | 111 | 3% (17) | 39% | $255,671 |
| 2016 | 633 | 101 | 2% (15) | 41% | $357,162 |
| 2015 | 638 | 106 | 5% (31) | 38% | $266,565 |
| 2014 | 564 | 87 | 5% (28) | 37% | $122,125 |
| 2013 | 499 | 93 | 6% (30) | 35% | $76,620 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Ocaliva | 12 | $105,581 | $8,798 |
| Xifaxan | 12 | $36,441 | $3,037 |
| Vemlidy | 24 | $35,622 | $1,484 |
| Linzess | 14 | $7,986 | $570 |
| Ursodiol | 28 | $3,258 | $116 |
| Esomeprazole Magnesium | 27 | $2,624 | $97 |
| Loperamide | 37 | $1,861 | $50 |
| Entecavir | 20 | $1,554 | $78 |
| Pantoprazole | 70 | $1,229 | $18 |
| Hyoscyamine Sulfate | 11 | $1,160 | $105 |
| Omeprazole | 57 | $1,005 | $18 |
| Lamivudine Hbv | 12 | $853 | $71 |
| Lactulose | 18 | $739 | $41 |
| Dicyclomine | 12 | $489 | $41 |
| Peg-3350 and Electrolytes | 20 | $478 | $24 |
| Lansoprazole | 15 | $394 | $26 |
| Spironolactone | 17 | $229 | $13 |
| Gavilyte-G | 11 | $222 | $20 |
| Amitriptyline | 23 | $137 | $6 |
| Furosemide | 11 | $72 | $7 |
2022: 18 drugs
| Ocaliva | 12 | $97,306 | $8,109 |
| Xifaxan | 13 | $37,558 | $2,889 |
| Vemlidy | 23 | $32,237 | $1,402 |
| Linzess | 25 | $10,261 | $410 |
| Ursodiol | 26 | $5,085 | $196 |
| Entecavir | 23 | $2,587 | $112 |
| Loperamide | 41 | $2,419 | $59 |
| Lansoprazole | 16 | $1,860 | $116 |
| Esomeprazole Magnesium | 14 | $1,455 | $104 |
| Lamivudine Hbv | 13 | $1,374 | $106 |
| Omeprazole | 35 | $820 | $23 |
| Pantoprazole | 55 | $791 | $14 |
| Lactulose | 15 | $516 | $34 |
| Peg-3350 and Electrolytes | 25 | $394 | $16 |
| Dicyclomine | 12 | $293 | $24 |
| Spironolactone | 15 | $180 | $12 |
| Amitriptyline | 21 | $135 | $6 |
| Clonazepam | 11 | $56 | $5 |
2021: 26 drugs
| Ocaliva | 12 | $91,885 | $7,657 |
| Xifaxan | 18 | $48,196 | $2,678 |
| Entecavir | 35 | $14,614 | $418 |
| Linzess | 29 | $13,594 | $469 |
| Creon | 20 | $9,133 | $457 |
| Colesevelam | 11 | $3,044 | $277 |
| Sucralfate | 14 | $2,901 | $207 |
| Tenofovir Disoproxil | 13 | $2,133 | $164 |
| Suprep | 18 | $1,840 | $102 |
| Esomeprazole Magnesium | 12 | $1,561 | $130 |
| Lamivudine Hbv | 12 | $1,444 | $120 |
| Loperamide | 35 | $1,406 | $40 |
| Ursodiol | 18 | $1,364 | $76 |
| Omeprazole | 57 | $767 | $13 |
| Lactulose | 14 | $710 | $51 |
| Lansoprazole | 20 | $669 | $33 |
| Pantoprazole | 56 | $631 | $11 |
| Dicyclomine | 17 | $596 | $35 |
| Spironolactone | 32 | $508 | $16 |
| Famotidine | 18 | $340 | $19 |
| Peg-3350 and Electrolytes | 22 | $305 | $14 |
| Acetaminophen-Codeine | 12 | $214 | $18 |
| Propranolol | 18 | $204 | $11 |
| Golytely | 15 | $193 | $13 |
| Furosemide | 11 | $66 | $6 |
| Clonazepam | 11 | $58 | $5 |
2020: 19 drugs
| Xifaxan | 27 | $61,943 | $2,294 |
| Linzess | 38 | $17,585 | $463 |
| Creon | 25 | $10,150 | $406 |
| Ursodiol | 18 | $2,770 | $154 |
| Tenofovir Disoproxil | 21 | $2,549 | $121 |
| Esomeprazole Magnesium | 15 | $1,935 | $129 |
| Lamivudine Hbv | 12 | $1,444 | $120 |
| Dicyclomine | 26 | $916 | $35 |
| Lactulose | 16 | $811 | $51 |
| Entecavir | 17 | $624 | $37 |
| Famotidine | 20 | $561 | $28 |
| Pantoprazole | 61 | $507 | $8 |
| Peg-3350 and Electrolytes | 29 | $385 | $13 |
| Spironolactone | 32 | $385 | $12 |
| Loperamide | 15 | $367 | $24 |
| Omeprazole | 40 | $335 | $8 |
| Gavilyte-G | 13 | $195 | $15 |
| Lorazepam | 12 | $177 | $15 |
| Propranolol | 14 | $161 | $12 |
2019: 22 drugs
| Humira | 13 | $61,256 | $4,712 |
| Xifaxan | 27 | $61,071 | $2,262 |
| Creon | 40 | $17,330 | $433 |
| Linzess | 26 | $11,340 | $436 |
| Ursodiol | 22 | $6,629 | $301 |
| Tenofovir Disoproxil | 30 | $3,690 | $123 |
| Meperidine | 12 | $1,965 | $164 |
| Lamivudine Hbv | 13 | $1,623 | $125 |
| Esomeprazole Magnesium | 36 | $1,608 | $45 |
| Entecavir | 15 | $734 | $49 |
| Dicyclomine | 34 | $714 | $21 |
| Calcitriol | 12 | $691 | $58 |
| Peg-3350 and Electrolytes | 51 | $683 | $13 |
| Pantoprazole | 57 | $457 | $8 |
| Omeprazole | 59 | $333 | $6 |
| Proctozone-Hc | 12 | $288 | $24 |
| Hydrocortisone | 12 | $278 | $23 |
| Famotidine | 11 | $248 | $23 |
| Propranolol | 16 | $245 | $15 |
| Spironolactone | 16 | $168 | $11 |
| Gavilyte-G | 11 | $165 | $15 |
| Lorazepam | 12 | $163 | $14 |
2018: 21 drugs
| Humira | 12 | $71,858 | $5,988 |
| Xifaxan | 20 | $39,652 | $1,983 |
| Linzess | 34 | $16,635 | $489 |
| Creon | 31 | $15,579 | $503 |
| Ursodiol | 13 | $12,321 | $948 |
| Viread | 15 | $10,269 | $685 |
| Tenofovir Disoproxil | 21 | $5,209 | $248 |
| Lamivudine Hbv | 12 | $3,879 | $323 |
| Mercaptopurine | 11 | $3,498 | $318 |
| Entecavir | 22 | $3,265 | $148 |
| Meperidine | 13 | $3,098 | $238 |
| Esomeprazole Magnesium | 23 | $2,410 | $105 |
| Peg-3350 and Electrolytes | 46 | $597 | $13 |
| Pantoprazole | 60 | $590 | $10 |
| Omeprazole | 67 | $572 | $9 |
| Calcitriol | 11 | $468 | $43 |
| Gavilyte-G | 17 | $253 | $15 |
| Dicyclomine | 26 | $224 | $9 |
| Ranitidine | 17 | $164 | $10 |
| Zolpidem | 13 | $94 | $7 |
| Lorazepam | 16 | $70 | $4 |
2017: 21 drugs
| Humira | 19 | $115,468 | $6,077 |
| Viread | 30 | $29,994 | $1,000 |
| Xifaxan | 14 | $25,151 | $1,797 |
| Creon | 31 | $14,673 | $473 |
| Linzess | 23 | $10,349 | $450 |
| Nexium | 13 | $9,682 | $745 |
| Lialda | 11 | $8,396 | $763 |
| Amitiza | 13 | $5,664 | $436 |
| Lamivudine Hbv | 12 | $4,127 | $344 |
| Entecavir | 13 | $3,666 | $282 |
| Meperidine | 14 | $3,325 | $237 |
| Esomeprazole Magnesium | 21 | $2,336 | $111 |
| Pantoprazole | 76 | $826 | $11 |
| Peg-3350 and Electrolytes | 36 | $464 | $13 |
| Omeprazole | 39 | $401 | $10 |
| Dicyclomine | 35 | $240 | $7 |
| Promethazine | 11 | $215 | $20 |
| Gavilyte-G | 11 | $171 | $16 |
| Ranitidine | 14 | $142 | $10 |
| Zolpidem | 13 | $84 | $6 |
| Lorazepam | 14 | $59 | $4 |
2016: 25 drugs
| Humira | 30 | $198,249 | $6,608 |
| Viread | 31 | $31,283 | $1,009 |
| Xifaxan | 16 | $27,164 | $1,698 |
| Ursodiol | 12 | $14,007 | $1,167 |
| Creon | 32 | $11,558 | $361 |
| Linzess | 25 | $10,018 | $401 |
| Entecavir | 13 | $9,678 | $744 |
| Nexium | 12 | $8,581 | $715 |
| Lialda | 11 | $7,941 | $722 |
| Lamivudine Hbv | 12 | $4,245 | $354 |
| Meperidine | 13 | $3,172 | $244 |
| Mercaptopurine | 23 | $1,039 | $45 |
| Esomeprazole Magnesium | 11 | $904 | $82 |
| Pantoprazole | 49 | $457 | $9 |
| Omeprazole | 56 | $401 | $7 |
| Sulfasalazine | 20 | $307 | $15 |
| Spironolactone | 14 | $203 | $15 |
| Gavilyte-G | 13 | $196 | $15 |
| Ranitidine | 19 | $169 | $9 |
| Gabapentin | 21 | $137 | $7 |
| Dicyclomine | 16 | $108 | $7 |
| Sertraline | 13 | $62 | $5 |
| Lorazepam | 14 | $56 | $4 |
| Furosemide | 15 | $25 | $2 |
| Zolpidem | 13 | $17 | $1 |
2015: 20 drugs
| Viread | 32 | $27,672 | $865 |
| Xifaxan | 16 | $22,682 | $1,418 |
| Entecavir | 17 | $16,541 | $973 |
| Nexium | 17 | $11,216 | $660 |
| Ursodiol | 11 | $9,681 | $880 |
| Creon | 29 | $7,596 | $262 |
| Lialda | 11 | $7,421 | $675 |
| Linzess | 21 | $5,243 | $250 |
| Lamivudine Hbv | 14 | $4,952 | $354 |
| Esomeprazole Magnesium | 12 | $4,735 | $395 |
| Meperidine | 13 | $2,060 | $158 |
| Mercaptopurine | 12 | $935 | $78 |
| Omeprazole | 79 | $633 | $8 |
| Pantoprazole | 28 | $286 | $10 |
| Peg 3350-Electrolyte | 25 | $251 | $10 |
| Propranolol | 14 | $216 | $15 |
| Dicyclomine | 33 | $193 | $6 |
| Ranitidine | 16 | $113 | $7 |
| Clonazepam | 18 | $85 | $5 |
| Lorazepam | 11 | $49 | $4 |
2014: 15 drugs
| Viread | 27 | $23,257 | $861 |
| Nexium | 36 | $21,397 | $594 |
| Xifaxan | 12 | $16,363 | $1,364 |
| Baraclude | 12 | $13,965 | $1,164 |
| Creon | 22 | $5,983 | $272 |
| Epivir Hbv | 12 | $4,487 | $374 |
| Omeprazole | 70 | $1,013 | $14 |
| Meperidine | 13 | $963 | $74 |
| Pantoprazole | 32 | $340 | $11 |
| Peg 3350-Electrolyte | 23 | $249 | $11 |
| Ranitidine | 16 | $127 | $8 |
| Dicyclomine | 16 | $121 | $8 |
| Clonazepam | 15 | $113 | $8 |
| Propranolol | 20 | $82 | $4 |
| Furosemide | 19 | $71 | $4 |
2013: 13 drugs
| Baraclude | 21 | $20,859 | $993 |
| Nexium | 39 | $14,536 | $373 |
| Creon | 20 | $7,734 | $387 |
| Omeprazole | 98 | $1,848 | $19 |
| Pantoprazole | 25 | $694 | $28 |
| Meperitab | 12 | $562 | $47 |
| Peg-3350 and Electrolytes | 12 | $197 | $16 |
| Peg 3350-Electrolyte | 14 | $178 | $13 |
| Clonazepam | 15 | $95 | $6 |
| Zolpidem | 14 | $91 | $6 |
| Furosemide | 14 | $79 | $6 |
| Propranolol | 13 | $62 | $5 |
| Ciprofloxacin | 12 | $51 | $4 |
Money from drug and device companies
$31 in 2023
A payment is not proof that care is biased.
| Erbe USA | Erbe Vio3 | $31 | 1 payment
|
See the published payment
| Erbe USA | Meals · 2023-06-29 | Erbe Vio3 | $31 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1144299926
- Licence
- CA G75546California G75546: Current · expires 2028-10-31
- Trained
- Perelman School of Med at the University of Pennsylvania, 1991
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G755460
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 751 S Bascom Ave, San Jose, CA, 95128
- NPI first listed
- 2006-03-15
- NPI last updated
- 2007-09-11
This is when the NPI record was last certified, not a medical board exam.